Related references
Note: Only part of the references are listed.Targeting Huntingtin Expression in Patients with Huntington's Disease
Sarah J. Tabrizi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
A divalent siRNA chemical scaffold for potent and sustained modulation of gene expression throughout the central nervous system
Julia F. Alterman et al.
NATURE BIOTECHNOLOGY (2019)
Translation of MicroRNA-Based Huntingtin-Lowering Therapies from Preclinical Studies to the Clinic
Jana Miniarikova et al.
MOLECULAR THERAPY (2018)
Comparison of partially and fully chemically-modified siRNA in conjugate-mediated delivery in vivo
Matthew R. Hassler et al.
NUCLEIC ACIDS RESEARCH (2018)
Widespread suppression of huntingtin with convection-enhanced delivery of siRNA
David K. Stiles et al.
EXPERIMENTAL NEUROLOGY (2012)
Sustained Therapeutic Reversal of Huntington's Disease by Transient Repression of Huntingtin Synthesis
Holly B. Kordasiewicz et al.
NEURON (2012)
Nonallele-specific Silencing of Mutant and Wild-type Huntingtin Demonstrates Therapeutic Efficacy in Huntington's Disease Mice
Ryan L. Boudreau et al.
MOLECULAR THERAPY (2009)
Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits
M. DiFiglia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model
SQ Harper et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Share Paper
